Abstract
The response to the harm caused by risk factors related to atherosclerosis may consist of clinical-signs of cardiac and/or blood vessel ischemic pathology sometimes accompanied by arrhythmias and heart failure-, metabolic- signs of altered oxygen transport and pro-thrombotic changes of coagulation-fibrinolysis cascade-, and sympathetic features due to nerve stimulation, which cause changes in heart rate and blood pressure. Moreover, some special categories like women have the responses, which are influenced by their endocrine constellation. There is a different predisposition towards the markers of atherosclerosis in premenopausal woman, who displays atherogenic effects, and in women after the menopause who respond similarly to that of men. Finally, oxidative stress, which is a strong pro-thrombotic factor, increases the development of an atherosclerotic lesion.
From these data, there is no doubt that a large number of factors, primarily smoking and endothelial dysfunction influence the cardiovascular system causing a major incidence of cardiovascular events. In addition, there would be evidence that some factors related to atherosclerosis should be considered as an etiologic (causal) factor of cardiovascular alterations because they can lead, in the long run, to an irreversible damage to the heart and blood vessels.
Keywords: Smoking, endothelium, atherosclerotic markers.
Current Pharmaceutical Design
Title:Markers of Atherosclerotic Disease: What do they Mean? Current Opinion and Future Trends
Volume: 22 Issue: 1
Author(s): Aurelio Leone
Affiliation:
Keywords: Smoking, endothelium, atherosclerotic markers.
Abstract: The response to the harm caused by risk factors related to atherosclerosis may consist of clinical-signs of cardiac and/or blood vessel ischemic pathology sometimes accompanied by arrhythmias and heart failure-, metabolic- signs of altered oxygen transport and pro-thrombotic changes of coagulation-fibrinolysis cascade-, and sympathetic features due to nerve stimulation, which cause changes in heart rate and blood pressure. Moreover, some special categories like women have the responses, which are influenced by their endocrine constellation. There is a different predisposition towards the markers of atherosclerosis in premenopausal woman, who displays atherogenic effects, and in women after the menopause who respond similarly to that of men. Finally, oxidative stress, which is a strong pro-thrombotic factor, increases the development of an atherosclerotic lesion.
From these data, there is no doubt that a large number of factors, primarily smoking and endothelial dysfunction influence the cardiovascular system causing a major incidence of cardiovascular events. In addition, there would be evidence that some factors related to atherosclerosis should be considered as an etiologic (causal) factor of cardiovascular alterations because they can lead, in the long run, to an irreversible damage to the heart and blood vessels.
Export Options
About this article
Cite this article as:
Leone Aurelio, Markers of Atherosclerotic Disease: What do they Mean? Current Opinion and Future Trends, Current Pharmaceutical Design 2016; 22 (1) . https://dx.doi.org/10.2174/1381612822666151109111311
DOI https://dx.doi.org/10.2174/1381612822666151109111311 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Poly(ADP-Ribosylation): Beneficial Effects of Its Inhibition
Current Enzyme Inhibition Anabolics in Osteoporosis: The Emerging Therapeutic Tool
Current Molecular Medicine Nutlin-3, A p53-Mdm2 Antagonist for Nasopharyngeal Carcinoma Treatment
Mini-Reviews in Medicinal Chemistry The Trigeminocardiac Reflex as Oxygen Conserving Reflex in Humans: Its Ischemic Tolerance Potential
Vascular Disease Prevention (Discontinued) Recent Patents on Proteasome Inhibitors of Natural Origin
Recent Patents on Anti-Cancer Drug Discovery Adipose Tissue in the Regulation of Inflammation
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Therapy Against Ischemic Injury
Current Pharmaceutical Design CPR Technique for Infants and Children
Current Pediatric Reviews Antihistamines: Past Answers and Present Questions
Current Drug Safety Will Global Transcriptome Analysis Allow the Detection of Novel Prognostic Markers in Coronary Artery Disease and Heart Failure?
Current Genomics Inhibitors of HIV-1 Protease: Current State of the Art 10 Years After their Introduction. From Antiretroviral Drugs to Antifungal, Antibacterial and Antitumor Agents Based on Aspartic Protease Inhibitors
Current Medicinal Chemistry Editorial [Hot Topic: Hot Topics in Cellular Cardiac Electrophysiology with Potential Impact on Future Drug Design (Guest Editors: Peter P. Nanasi and Valeria Kecskemeti)]
Current Medicinal Chemistry The Role of Wnt/Beta-Catenin Signaling in Renal Carcinogenesis: Lessons from Cadmium Toxicity Studies
Current Molecular Medicine Characterizing the Binding of Angiotensin Converting Enzyme I Inhibitory Peptide to Human Hemoglobin: Influence of Electromagnetic Fields
Protein & Peptide Letters Platelet-Derived Chemokines in Atherogenesis: What’s New?
Current Vascular Pharmacology <i>Nigella sativa</i> – A Functional Spice From A Pharaoh’s Tomb to Modern Healthcare
The Natural Products Journal HR+, HER2– Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of Action, Clinical Activity, and Safety Profiles
Current Cancer Drug Targets Editorial (Thematic Issue: What's Behind the Sex Gap in Cardiovascular Mortality?)
Current Pharmaceutical Design p53-Induced Apoptosis and Inhibitors of p53
Current Medicinal Chemistry Plant Polyphenols and Tumors: From Mechanisms to Therapies, Prevention, and Protection Against Toxicity of Anti-Cancer Treatments
Current Medicinal Chemistry